These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 939236)

  • 1. Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
    Dombernowsky P; Nissen NI
    Eur J Cancer (1965); 1976 Mar; 12(3):181-8. PubMed ID: 939236
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 3. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ; Sirica AE; Gang M; Kline I; Venditti JM
    Chemotherapy; 1973; 18(3):169-83. PubMed ID: 4119363
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy in malignant diseases.
    Fairley GH
    J R Coll Physicians Lond; 1971 Jan; 5(2):167-77. PubMed ID: 4950464
    [No Abstract]   [Full Text] [Related]  

  • 5. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM; Helfman D
    Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1973 treatment of acute leukemias].
    Danieli G
    Minerva Med; 1974 Dec; 65(90):4742-53. PubMed ID: 4141485
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of acute lymphocytic leukemia.
    Zubrod CG
    J Chronic Dis; 1970 Mar; 22(10):633-5. PubMed ID: 5271320
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
    Rivera G; Avery T; Roberts DW
    Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of 6-N-hydroxylamino-9-beta-D-ribofuranosylpurine in mouse leukemia.
    Burchenal JH; Dollinger M; Butterbaugh J; Stoll D; Giner-Sorolla A
    Biochem Pharmacol; 1967 Mar; 16(3):423-8. PubMed ID: 6034363
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST; Bleyer WA
    Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute leukemias and Burkitt's lymphoma. Present status of therapy.
    Zubrod CG
    Cancer; 1968 Apr; 21(4):553-7. PubMed ID: 4296158
    [No Abstract]   [Full Text] [Related]  

  • 14. [Burkitt's lymphoma and acute leukemias].
    Ravina A
    Presse Med (1893); 1969 Feb; 77(7):245-6. PubMed ID: 4895891
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guide to the use of cancer chemotherapeutic agents.
    Bergevin PR; Tormey DC; Blom J
    Mod Treat; 1972 May; 9(2):185-273. PubMed ID: 4117324
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.
    Wollner N; Burchenal JH; Lieberman PH; Exelby P; D'Angio G; Murphy ML
    Cancer; 1976 Jan; 37(1):123-34. PubMed ID: 1247950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine neuroblastoma: a model of human disease.
    Finklestein JZ; Arima E; Byfield PE; Byfield JE; Fonkalsrud EW
    Cancer Chemother Rep; 1973; 57(4):405-12. PubMed ID: 4762439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.